Zhiwei Wang

USPTO Granted Patents = 63 (Patent Applications = 75)

CIPO Patents = 4 (Patent Applications = 16)

EPO Patents = 9 (Patent Applications = 57)

Average Co-Inventor Count = 4.0

ph-index = 8

Forward Citations = 196(Granted Patents)

Forward Citations (Not Self Cited) = 97(Dec 10, 2025)

Company Filing History:

Beigene Switzerland Gmbh

patents

4. 2 out of 2

Beone Medicines I Gmbh

patents

5. 1 out of 4,945

Hoffmann-la Roche Inc.

patents

6. 1 out of 23

China Three Gorges Corporation

patents

7. 1 out of 164,197

International Business Machines Corporation

patents

Years Active: 2016-2025

Loading Chart...

Areas of Expertise:

Wireless Communication

HPK1 Inhibitors

Cyclic Dinucleotides

MIMO Transmissions

BCL-2 Inhibitors

Subscriber Identity Modules

Throughput Optimization

Fake Base Station Detection

Indoleamine Inhibitors

Bruton's Tyrosine Kinase

Adaptive Data Collection

VoLTE Setup

63 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12477567 - Reduction of latency in wireless communication systems (2025-11-18),

2. 12459958 - Tricyclic compounds as HPK1 inhibitor and the use thereof (2025-11-04),

3. 12454534 - Pyrrolo[2,3-b]pyrazines as HPK1 inhibitor and the use thereof (2025-10-28),

4. 12435104 - Cyclic dinucleotides as sting agonists (2025-10-07),

5. 12425984 - Dynamic transmission power backoff (2025-09-23),

6. 12403210 - User equipment having multiple subscriber identity modules with improved suspend / resume operation (2025-09-02),

7. 12389368 - Adjust paging occasion to resolve paging collision at a multi-SIM device (2025-08-12),

8. 12355699 - Method of codebook sounding reference signal (SRS) antenna mapping to improve uplink performance (2025-07-08),

9. 12286430 - Bcl-2 inhibitor (2025-04-29),

10. 12250033 - Imbalance compensation for uplink (UL)—multiple-input and multiple-output (MIMO) transmissions (2025-03-11),

11. 12214099 - User equipment having multiple subscriber identity modules with improved suspend / resume operation (2025-02-04),

12. 12213067 - Handling transmit and receive blanking for multi-RAT and DSDA capable wireless devices (2025-01-28),

13. 12195449 - 3-[(1H-pyrazol-r-yl)oxy]pyrazin-2-amine compounds as HPK1 inhibitor and use thereof (2025-01-14),

14. 12158022 - Gap caulking device and a caulking method (2024-12-03),

15. 12103931 - Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof (2024-10-01),

Title: The Innovative Contributions of Zhiwei Wang

Introduction: Zhiwei Wang, a distinguished inventor based in Beijing, CN, has made significant strides in the realm of innovation with a remarkable portfolio of 55 patents to his name. His work spans various fields, showcasing his ability to solve complex challenges through innovative solutions.

Latest Patents: Among his latest patents is a groundbreaking Bcl-2 inhibitor, which presents a compound of Formula (I) aimed at inhibiting both wild type and mutated forms of Bcl-2, particularly G101V and D103Y. This invention holds promise for treating dysregulated apoptotic diseases, offering new avenues for medical intervention. Another notable patent focuses on imbalance compensation for uplink (UL)—multiple-input and multiple-output (MIMO) transmissions. This invention includes systems, methods, and apparatuses that compensate for imbalances between multiple transport streams in UL-MIMO transmission, enhancing signal metrics and adjusting for imbalances through methods such as injecting noise into transmission streams.

Career Highlights: Throughout his career, Zhiwei Wang has collaborated with prominent companies, including Apple Inc. and BeiGene, Ltd., where he contributed to cutting-edge research and development. His work has not only advanced technology but has also paved the way for new industry standards in the fields he operates in.

Collaborations: Zhiwei has worked alongside talented individuals such as Yunhang Guo and Yaoqi Yan. These collaborations have fostered a rich environment for creativity and innovation, leading to the development of impactful technologies.

Conclusion: Zhiwei Wang's contributions to the field of innovation through his patents and collaborations illustrate the vital role of inventors in advancing technology. His work continues to inspire future innovations and highlights the importance of collaborative efforts in achieving remarkable breakthroughs.

This text is generated by artificial intelligence and may not be accurate.